James Paul Lang

OPRX

James Paul Lang serves as Director at OptimizeRx Corporation (OPRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$2.54M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$2.54M

Companies Traded

OPRX

Active Period

Aug 2022 – Mar 2025

2 total trades

Most Recent

Buy OPRX

Mar 14, 2025 · $2.44M

James Paul Lang's Insider Trading at OptimizeRx Corporation (OPRX)

Buys

2 · $2.54M

Sells

0 · $0.00

Total Shares Bought

327,408

Total Shares Sold

OPRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 14, 2025	Buy	321,408	$7.60	$2.44M	0
Aug 23, 2022	Buy	6,000	$16.45	$98.7K	38,660

Related Insiders

Marion Odence-Ford

Chief Legal & Admin Officer

OPRXSell · Feb 11, 2026

Theresa Greco

Chief Commercial Officer

OPRXSell · Dec 23, 2025

Edward Stelmakh

Chief Finance & Strat Officer

OPRXSell · Dec 23, 2025

Stephen L Silvestro

Chief Executive Officer

OPRXSell · Dec 23, 2025

Doug Besch

Chief Product & Tech Officer

OPRXSell · Dec 23, 2025

Brendan W. Merrell

CHIEF OPERATING OFFICER

OPRXSell · Dec 19, 2025

Andrew J. D'Silva

Chief Business Officer

OPRXSell · Dec 19, 2025

Patrick D Spangler

Director

OPRXSell · Aug 28, 2025

Explore More Insider Trading Data

OPRX Insider Trading Activity

View all insider trades at OptimizeRx Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity